CD30, another diagnostic marker, is a surface marker for neoplastic cells of Hodgkin’s lymphoma [27], and CD30 positivity is seen in 80%-100% of cases of cHL and anaplastic large cell lymphoma [28,29], while CD15 is a characteristic marker in cHL and is seen to be positive in 80% of cases. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.